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This paper announces the genome sequence and annotation of the genetically modified (GM) Bacillus subtilis strain 2014-3557
overproducing riboflavin (vitamin B2). This GM-strain is unauthorized in the European Union. Nevertheless, it has been iso-
lated from a lot of vitamin B2 (riboflavin) 80% feed grade imported to Europe from China.
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Riboflavin (vitamin B2) cannot be biosynthesized by verte-brates, whereas plant and most microorganisms are able to
do so (1). Therefore, vitamin B2 is used as a food and feed
additive. As an alternative to costly chemical synthesis, micro-
bial fermentation processes of riboflavin were developed for
industrial production. Naturally producing or riboflavin-
overproducing microorganisms transformed by a genetic engi-
neering, chemical, or physical process can be used. Bacillus
subtilis, a Gram-positive, rod-shaped bacterium, is exploited in
industry for this purpose (1–3).
In July 2014, Germany detected a viable Bacillus subtilis strain
which harbored a non-naturally occurring combination of DNA
sequences in a lot of vitamin B2 feed additive imported from
China. This strain was considered as genetically modified and un-
known; therefore it is unauthorized in the European Union. In
September 2014, the European Rapid Alert System for Food and
Feed (RASFF) created a notification to alert the other European
countries about the presence of the unauthorized GM-Bacillus
subtilis in this particular vitamin B2 feed additive (https://webgate
.ec.europa.eu/rasff-window/portal/ [enter reference 2014.1249]).
Consequently, the French competent authorities investigated
this kind of product imported in France. A French National Ref-
erence Laboratory (NRL) for GMO isolated a yellow substance
(presumably overproduction of riboflavin)-secreting bacterial
strain from three samples of vitamin B2 feed additives imported
from China.
To further characterize this finding, whole-genome sequenc-
ing was performed on one of the three isolates with an Illumina
HiSeq2500 run using a paired-end library. Sequencing yielded
10,914,314 paired-end reads (350-fold coverage), which were as-
sembled de novo using CLC Genomics Workbench version 7.5.1
(CLC Bio). The resulting draft genome was further linked into
scaffolds with SSPACE (4) based on paired-end read linkage. Fi-
nally, a total of 39 gap-closed scaffolds were generated consisting
of 143 contigs with a maximum gap-closed scaffold size of
1,018,461 bp and aminimum size of 370 bp. After filtering of these
39 scaffolds, three were discarded as two matched with Homo
sapiens and one with Haemonchus placei. The total sequence
length post-filtering is 4,175,764 bp, and has a GC content of
44.32%.
Genome annotation was performed on the assembled scaf-
fold sequences using the BaseClear annotation pipeline which
is based on the Prokka Prokaryotic Genome Annotation Sys-
tem. This annotation confirmed the organism as Bacillus sub-
tilis with 100% identity. 4,233 genes were predicted, of which
4,144 have a known function, including several encoding for
proteins involved in riboflavin synthesis and transport. The
genome sequence of this Bacillus subtilis strain will be useful for
further characterization of its GM nature and in developing a
specific method for its detection in food and feed additives by
enforcement laboratories.
Nucleotide sequence accessionnumbers.Thiswhole-genome
shotgun project has been deposited at DDBJ/EMBL/GenBank un-
der the accession no. JYFL00000000. The version described in this
paper is version JYFL01000000.
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